Marjorie E. Winkler

4.5k citations

28 papers · 3.7k indexed · 2 hit papers · h-index 22

Impact in

Oncology top 2%
- HER2/EGFR in Cancer Research
- Bone health and treatments
Molecular Biology top 5%
- TGF-β signaling in diseases
- Glycosylation and Glycoproteins Research
- Bone Metabolism and Diseases
- Angiogenesis and VEGF in Cancer

Papers in

Biotechnology 4
- Enzyme Production and Characterization 3
Endocrinology, Diabetes and Metabolism 7
- Growth Hormone and Insulin-like Growth Factors 7

Co-authors: Rik Derynck Alain B. Schreiber Anita B. Roberts Erik De Clercq Ellson Y. Chen David V. Goeddel Edward I. Solomon Konrad Lerch
Journals: Biochemistry (5 papers)Journal of the American Chemical Society (3 papers)Journal of Clinical Investigation (2 papers)Nature Biotechnology (2 papers)Proceedings of the National Academy of Sciences (2 papers)
Partner nations: United States United Kingdom Poland

In The Last Decade

Marjorie E. Winkler

28 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

Transforming Growth Factor-α: a More Potent Angiogenic Mediator than Epidermal Growth Factor 1986 · 706 citations

Peers

Countries citing papers authored by Marjorie E. Winkler

Since Specialization

Citations

This map shows the geographic impact of Marjorie E. Winkler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjorie E. Winkler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjorie E. Winkler more than expected).

Fields of papers citing papers by Marjorie E. Winkler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjorie E. Winkler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjorie E. Winkler. The network helps show where Marjorie E. Winkler may publish in the future.

Co-authors

The 25 scholars most cited alongside Marjorie E. Winkler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marjorie E. Winkler Line = papers co-authored together Marjorie E. Winkler links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Glycoengineering of Therapeutic Glycoproteins: In Vitro Galactosylation and Sialylation of Glycoproteins with Terminal N-Acetylglucosamine and Galactose Residues Biochemistry ·T. Shantha Raju, John B. Briggs, Steven M. Chamow, Marjorie E. Winkler, Andrew J. S. Jones	2001	89
2	Purification of plasmid DNA by tangential flow filtration Biotechnology and Bioengineering ·David W. Kahn, Michelle D. Butler, Darien L. Cohen, Margaret J. Gordon, Jeanne W. Kahn, Marjorie E. Winkler	2000	66
3	Long-acting Growth Hormones Produced by Conjugation with Polyethylene Glycol Journal of Biological Chemistry ·Ross Clark, K. C. Olson, Germaine Fuh, Melinda Marian, Deborah L. Mortensen, Glen Teshima, Suh Chang, Herman Chu, Venkat R. Mukku, Eleanor Canova‐Davis, Todd C. Somers, Michael J. Cronin, Marjorie E. Winkler, James A. Wells	1996	201
4	Solution structure of human type-.alpha. transforming growth factor determined by heteronuclear NMR spectroscopy and refined by energy minimization with restraints Biochemistry ·Franklin J. Moy, Yu Chin Li, P B Rauenbuehler, Marjorie E. Winkler, Harold A. Scheraga, G.T. Montelione	1993	46
5	Polyethylene Glycol Enhanced Protein Refolding Nature Biotechnology ·Jeffrey L. Cleland, Stuart E. Builder, James R. Swartz, Marjorie E. Winkler, Judy Y. Chang, Daniel I. C. Wang	1992	149
6	Contribution of the C-terminal dipeptide of transforming growth factor-α to its activity: biochemical and pharmacologic profiles European Journal of Pharmacology Molecular Pharmacology ·Song‐Gui Yang, Marjorie E. Winkler, Morley D. Hollenberg	1990	5
7	Folding of Eukaryotic Proteins Produced in Escherichia Coli PubMed ·Robert F. Kelley, Marjorie E. Winkler	1990	8
8	Epidermal growth factor and transforming growth factor .alpha. bind differently to the epidermal growth factor receptor Biochemistry ·Marjorie E. Winkler, Lynn H. O’Connor, Marcy Winget, B M Fendly	1989	111
9	Accurate measurements of long-range heteronuclear coupling constants from homonuclear 2D NMR spectra of isotope-enriched proteins Journal of Magnetic Resonance (1969) ·G.T. Montelione, Marjorie E. Winkler, P B Rauenbuehler, Gerhard Wagner	1989	113
10	Functional role of proteolytic cleavage at arginine-275 of human tissue plasminogen activator as assessed by site-directed mutagenesis Biochemistry ·Keri Tate, Deborah L. Higgins, William E. Holmes, Marjorie E. Winkler, Herbert L. Heyneker, Gordon A. Vehar	1987	118
11	Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proceedings of the National Academy of Sciences ·A H Tashjian, Edward F. Voelkel, Marc A. Lazzaro, Frederick R. Singer, Anita B. Roberts, Rik Derynck, Marjorie E. Winkler, Lawrence Levine	1985	318
12	Substrate analog binding to the coupled binuclear copper active site in tyrosinase Journal of the American Chemical Society ·Dean E. Wilcox, Arturo G. Porras, Yeong Tsyr Hwang, Konrad Lerch, Marjorie E. Winkler, Edward I. Solomon	1985	262
13	Human transforming growth factor-α: Precursor structure and expression in E. coli Cell ·Erik De Clercq, Anita B. Roberts, Marjorie E. Winkler, Ellson Y. Chen, David V. Goeddel Hit paper breakdown →	1984	775
14	Anion binding to oxidized type 2 depleted and native laccase: A spectroscopically effective model for exogenous ligand binding to the type 3 - type 2 active site Biochemical and Biophysical Research Communications ·Marjorie E. Winkler, Darlene J. Spira, Cynthia D. LuBien, Thomas J. Thamann, Edward I. Solomon	1982	35
15	Preparation and characterization of a stable half met derivative of type 2 depleted Rhus laccase: Exogenous ligand binding to the type 3 site Biochemical and Biophysical Research Communications ·Darlene J. Spira, Marjorie E. Winkler, Edward I. Solomon	1982	22
16	Competitive inhibitor binding to the binuclear copper active site in tyrosinase Journal of the American Chemical Society ·Marjorie E. Winkler, Konrad Lerch, Edward I. Solomon	1981	79
17	A spectral investigation of the copper(II) complex of the antitumor compound bleomycin Journal of Inorganic Biochemistry ·Robert D. Bereman, Marjorie E. Winkler	1980	15
18	Stereoelectronic properties of metalloenzymes. 6. Effects of anions and ferricyanide on the copper(II) site of the histidine and the tryptophan modified forms of galactose oxidase Journal of the American Chemical Society ·Marjorie E. Winkler, Robert D. Bereman	1980	16
19	Inhibition of calf thymus DNA polymerase-alpha by deoxyribonucleoside triphosphates. PubMed ·Gerald B. Grindey, Marjorie E. Winkler, Maureen Otten, Jay A. Steinberg	1980	5
20	Coordination chemistry of the antitumor compound bleomycin A spectral investigation of the cobalt complex Journal of Inorganic and Nuclear Chemistry ·Robert D. Bereman, Marjorie E. Winkler	1980	2

About Marjorie E. Winkler

Marjorie E. Winkler is a scholar working on Biotechnology, Endocrinology, Diabetes and Metabolism, Oncology, Toxicology and Molecular Biology, having authored 28 papers that have together received 3.7k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (7 papers), TGF-β signaling in diseases (5 papers), Peptidase Inhibition and Analysis (4 papers), melanin and skin pigmentation (3 papers), Enzyme Structure and Function (3 papers), Enzyme Production and Characterization (3 papers), Metal complexes synthesis and properties (3 papers) and Electrochemical sensors and biosensors (2 papers). The work is most often cited by research in Oncology (1.1k citations), Molecular Biology (2.2k citations), Immunology and Allergy (184 citations), Cancer Research (423 citations) and Endocrinology, Diabetes and Metabolism (430 citations). Marjorie E. Winkler has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Rik Derynck, Alain B. Schreiber, Anita B. Roberts, Erik De Clercq, Ellson Y. Chen, David V. Goeddel, Edward I. Solomon, Konrad Lerch, A H Tashjian and Edward F. Voelkel. Their work appears in journals such as Biochemistry, Journal of the American Chemical Society, Journal of Clinical Investigation, Nature Biotechnology and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact